ロード中...
High-risk Stage II Colorectal Cancers Carry an Equivalent Risk of Peritoneal Recurrence to Stage III
Background/Aim: Several risk factors for recurrence have been identified in stage II colorectal cancer. However, in contrast to stage III, the benefits of adjuvant chemotherapy for these patients remain controversial. We hypothesized that the different impacts of chemotherapy may be due to different...
保存先:
| 出版年: | In Vivo |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
International Institute of Anticancer Research
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6199616/ https://ncbi.nlm.nih.gov/pubmed/30150450 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11370 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|